Sanofi News

6-K: 15.7% Sales Growth Boosted by Earlier-Than-Anticipated Vaccine Sales; 2024 Business Eps Guidance Raised Due to Strong Business Performance

Oct 25 12:42 ET

6-K: Sanofi Reports Strong Second Quarter Results with 10% Sales Growth; 2024 Guidance Upgraded

Jul 25 11:48 ET

6-K: 2024 Half-Year Financial Report

Jul 25 10:29 ET

Sanofi | 6-K: Colletion of Recent Announcements

May 2 15:56 ET

Sanofi | 6-K: Sanofi Q1 Robust 7% Sales Growth Driven by Launches, Underpins Full-Year Guidance

Apr 25 10:55 ET

Sanofi | 20-F: FY2023 Annual Report

Feb 23 11:20 ET

Sanofi | 6-K: Sanofi Delivers Solid Sales and Business EPS Growth at CER Amidst Successful Product Launches and Advancements in Immunology Pipeline

Feb 1 09:46 ET

Sanofi | 6-K: Report of foreign private issuer (related to financial reporting)

Jul 28, 2023 15:35 ET

Sanofi | 6-K: Report of foreign private issuer (related to financial reporting)

Jul 28, 2023 07:00 ET

Sanofi | 6-K: Report of foreign private issuer (related to financial reporting)

Jun 2, 2023 10:53 ET

Sanofi | 6-K: Report of foreign private issuer (related to financial reporting)

Apr 27, 2023 11:39 ET

Sanofi | 6-K: Report of foreign private issuer (related to financial reporting)

Mar 13, 2023 07:38 ET

Sanofi | 6-K: Report of foreign private issuer (related to financial reporting)

Feb 24, 2023 17:20 ET

Sanofi | 20-F: FY2022 Annual Report

Feb 24, 2023 10:25 ET

Sanofi | 6-K: Report of foreign private issuer (related to financial reporting)

Feb 3, 2023 11:40 ET

Sanofi | 6-K: Report of foreign private issuer (related to financial reporting)

Oct 28, 2022 11:16 ET

Sanofi | 6-K: Report of foreign private issuer (related to financial reporting)

Sep 22, 2022 09:49 ET

Sanofi | 6-K: Report of foreign private issuer (related to financial reporting)

Jul 28, 2022 10:12 ET

Sanofi | 6-K: Report of foreign private issuer (related to financial reporting)

Jul 28, 2022 06:17 ET

Sanofi | 6-K: Report of foreign private issuer (related to financial reporting)

May 17, 2022 15:20 ET